HER2-targeted Antibodies

All categories
Name
HER2-targeted Antibodies
Accession Number
DBCAT005683
Description

Not Available

Drugs
DrugDrug Description
Trastuzumab emtansineAn antineoplastic agent and antibody-drug conjugate used to treat HER2-overexpressing breast cancer.
Drugs & Drug Targets
DrugTargetType
Trastuzumab emtansineReceptor tyrosine-protein kinase erbB-2target
Trastuzumab emtansineP-glycoprotein 1transporter
Trastuzumab emtansineCytochrome P450 3A4enzyme
Trastuzumab emtansineCytochrome P450 3A5enzyme